Skip to main content
. 2015 Nov 3;56(12):1921–1930. doi: 10.1111/epi.13224

Figure 2.

Figure 2

Subgroup responder rate (percentage of patients who experienced a ≥50% and ≥75% reduction in seizure frequency or seizure freedom compared with baseline) analyses at the final visit (mFAS). Percentage calculations are based on the number of subjects (N) at the final 6‐month visit. (A) Number of lifetime AEDs. (B) Age subgroup analysis. (C) Duration of epilepsy. AEDs, antiepileptic drugs; mFAS, modified full analysis set.